肝细胞癌中浆细胞向免疫球蛋白G表型极化涉及表观遗传改变并促进小鼠肝癌进展
该研究分析了342例肝细胞癌(HCC)患者样本中浆细胞亚群分布,发现HCC中B细胞发生类别转换重组为IgG表型,浆细胞增多与不良预后相关;机制上CD4+ T细胞刺激巨噬细胞产生CXCL10,CXCL10通过CXCR3-ERK信号促使B细胞分化为IgG浆细胞,IgG激活巨噬细胞Fc受体产生IL-6、IL-10和CCL20抑制抗肿瘤T细胞反应;小鼠肝癌中清除B细胞可减少上述巨噬细胞、增强抗肿瘤T细胞反应并减缓肿瘤生长,该通路涉及DNA甲基转移酶1和EZH2表达增加。
要点
- HCC组织中B细胞发生体细胞超突变和类别转换重组为IgG表型,非肿瘤组织未见。
- 浆细胞水平升高与HCC患者不良预后相关。
- 小鼠肝癌中清除B细胞可增强抗肿瘤T细胞反应并减少肿瘤生长。
核心结论
- 人HCC组织含发生类别转换重组为IgG表型的B细胞,该过程由CD4+ T细胞刺激巨噬细胞产生CXCL10、CXCL10结合B细胞CXCR3并经ERK信号驱动,IgG激活巨噬细胞Fc受体产生IL-6、IL-10和CCL20降低抗肿瘤免疫反应。
- 小鼠肝癌中清除B细胞可阻止上述巨噬细胞生成、增强抗肿瘤T细胞反应并减少肝癌生长,该通路涉及HCC和肝癌细胞DNA甲基转移酶1和EZH2表达增加。
研究设计与样本
- 分析中国中山大学肿瘤防治中心342例接受根治性切除术的HCC患者样本中浆细胞亚群组成与分布,以非肿瘤肝组织为对照,并将浆细胞特征与患者结局关联。
- 采用流式细胞术和实时聚合酶链反应分析组织来源白细胞,用离体培养人HCC组织细胞确定巨噬细胞调节浆细胞分化的能力。
- 给C57BL/6和BALB/c小鼠注射Hepa1-6细胞(形成肝癌)或H22细胞(形成腹水型肝癌),并用实时聚合酶链反应分析人HCC、小鼠肝癌和非肿瘤组织的基因表达模式。
- 给荷肝癌小鼠注射GSK126(组蛋白H3赖氨酸27甲基转移酶EZH2抑制剂)和5-AZA-dC(DNA甲基转移酶抑制剂),用免疫荧光和免疫组化分析肿瘤组织免疫细胞和细胞因子。
主要发现
- 从HCC分离的B细胞具有体细胞超突变和类别转换重组为IgG表型,非肿瘤组织未观察到。
- 浆细胞水平升高与患者不良预后相关。
- HCC中活化CD4+ T细胞刺激巨噬细胞产生CXCL10,CXCL10结合B细胞上CXCR3并通过细胞外信号调节激酶信号使其成为产生IgG的浆细胞。
- IgG激活巨噬细胞Fc受体诱导其产生白细胞介素6、白细胞介素10和C-C基序趋化因子配体20(CCL20)。
- 小鼠肝癌中清除B细胞可阻止上述巨噬细胞生成、增强抗肿瘤T细胞反应并减少肝癌生长,但注射CXCR3阳性浆细胞后这些效应消失。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Little is known about the composition and generation of plasma cell subsets in patients with hepatocellular carcinoma (HCC) and how these associate with outcomes. We investigated whether, or how, plasma cells differentiate and function in patients with HCC and mice with liver tumors. METHODS: We analyzed subset composition and distribution of plasma cells in HCC samples from 342 patients who underwent curative resection at the Cancer Center of Sun Yat-sen University in China; samples of non-tumor liver tissue were used as controls. We associated plasma cell profiles with patient outcomes. Tissue-derived leukocytes were analyzed by flow cytometry and real-time polymerase chain reaction. The ability of macrophages to regulate plasma cell differentiation was determined in ex vivo cultures of cells from human HCC tissues. C57BL/6 and BALB/c mice were given injections of Hepa1-6 cells, which formed hepatomas, or H22 cells, which formed ascitic hepatomas. Gene expression patterns were analyzed in human HCC, mouse hepatoma, and non-tumor tissues by real-time polymerase chain reaction. Mice with hepatomas were given injections of GSK126 (an inhibitor of histone H3 lysine 27 methyltransferase [EZH2]) and 5-AZA-dC (an inhibitor of DNA methyltransferases); tumor tissues were analyzed by immunofluorescence and immunohistochemistry for the presence of immune cells and cytokines. RESULTS: B cells isolated from HCCs had somatic hypermutations and class-switch recombinations to the IgG phenotype that were not observed in non-tumor tissues. Increased level of plasma cells correlated with poor outcomes of patients. Activated CD4+ T cells from HCCs stimulated C-X-C motif chemokine 10 (CXCL10) production by macrophages. CXCL10 bound CXC chemokine receptor 3 on B cells and signaled via extracellular signal-regulated kinase to cause them to become IgG-producing plasma cells. IgG activated Fc receptors on macrophages and induced them to produce interleukin 6, interleukin 10, and C-C motif chemokine ligand 20 (CCL20). In mice with hepatomas, depletion of B cells prevented generation of these macrophage, increased the anti-tumor T cell response, and reduced growth of hepatomas. However, these effects were lost after injection of CXC chemokine receptor 3-positive plasma cells. Human HCC and mouse hepatoma tissues had increased expression of DNA methyltransferase 1 and EZH2 compared with non-tumor tissues. Injection of mice with GSK126 and 5-AZA-dC induced expression of CXCL10 by tumor cells and caused plasma cell polarization, suppression of the anti-tumor T cell response, and hepatoma growth. CONCLUSIONS: Human HCC tissues contain B cells with class-switch recombinations to the IgG phenotype. Activated CD4+ T cells from HCCs stimulate CXCL10 production by macrophages; CXCL10 binds CXC chemokine receptor 3 on B cells and causes them to become IgG-producing plasma cells. IgG activates Fc receptor in macrophages to produce cytokines that reduce the anti-tumor immune response. In mice with hepatomas, depletion of B cells prevented generation of these macrophages, increased the anti-tumor T cell response, and reduced growth of hepatomas. This pathway involves increased expression of DNA methyltransferase 1 and EZH2 by HCC and hepatoma cells.
引用
- Wei Y, Lao XM, Xiao X, et al. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice. Gastroenterology. 2019. PMID: 30711627. doi:10.1053/j.gastro.2019.01.250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。